SG11202112712RA - Methods for modulating a treatment regimen - Google Patents
Methods for modulating a treatment regimenInfo
- Publication number
- SG11202112712RA SG11202112712RA SG11202112712RA SG11202112712RA SG11202112712RA SG 11202112712R A SG11202112712R A SG 11202112712RA SG 11202112712R A SG11202112712R A SG 11202112712RA SG 11202112712R A SG11202112712R A SG 11202112712RA SG 11202112712R A SG11202112712R A SG 11202112712RA
- Authority
- SG
- Singapore
- Prior art keywords
- modulating
- methods
- treatment regimen
- regimen
- treatment
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/7051—T-cell receptor (TcR)-CD3 complex
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70517—CD8
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19177991 | 2019-06-03 | ||
| EP19305711 | 2019-06-03 | ||
| PCT/EP2020/065289 WO2020245155A1 (en) | 2019-06-03 | 2020-06-03 | Methods for modulating a treatment regimen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202112712RA true SG11202112712RA (en) | 2021-12-30 |
Family
ID=70861510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202112712RA SG11202112712RA (en) | 2019-06-03 | 2020-06-03 | Methods for modulating a treatment regimen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220236276A1 (en) |
| EP (1) | EP3977130A1 (en) |
| JP (1) | JP2022536075A (en) |
| CN (1) | CN114072676A (en) |
| AU (1) | AU2020288603A1 (en) |
| BR (1) | BR112021024374A8 (en) |
| CA (1) | CA3142293A1 (en) |
| IL (1) | IL288491A (en) |
| SG (1) | SG11202112712RA (en) |
| WO (1) | WO2020245155A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202007099D0 (en) | 2020-05-14 | 2020-07-01 | Kymab Ltd | Tumour biomarkers for immunotherapy |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4888278A (en) | 1985-10-22 | 1989-12-19 | University Of Massachusetts Medical Center | In-situ hybridization to detect nucleic acid sequences in morphologically intact cells |
| US5447841A (en) | 1986-01-16 | 1995-09-05 | The Regents Of The Univ. Of California | Methods for chromosome-specific staining |
| US6280929B1 (en) | 1986-01-16 | 2001-08-28 | The Regents Of The University Of California | Method of detecting genetic translocations identified with chromosomal abnormalities |
| US5427932A (en) | 1991-04-09 | 1995-06-27 | Reagents Of The University Of California | Repeat sequence chromosome specific nucleic acid probes and methods of preparing and using |
| US5472842A (en) | 1993-10-06 | 1995-12-05 | The Regents Of The University Of California | Detection of amplified or deleted chromosomal regions |
| US7214477B1 (en) | 1999-07-26 | 2007-05-08 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Layered device with capture regions for cellular analysis |
| US6969615B2 (en) | 1999-07-26 | 2005-11-29 | 20/20 Genesystems, Inc. | Methods, devices, arrays and kits for detecting and analyzing biomolecules |
| ES2269171T3 (en) | 1999-07-26 | 2007-04-01 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Heal | LAYER DEVICE WITH CAPTURE REGIONS FOR CELL ANALYSIS. |
| US7838222B2 (en) | 1999-07-26 | 2010-11-23 | United States of America/ NIH | Methods, devices and kits for multiplex blotting of biological samples from multi-well plates |
| US6942970B2 (en) | 2000-09-14 | 2005-09-13 | Zymed Laboratories, Inc. | Identifying subjects suitable for topoisomerase II inhibitor treatment |
| US7219016B2 (en) | 2001-04-20 | 2007-05-15 | Yale University | Systems and methods for automated analysis of cells and tissues |
| HU2464U (en) | 2002-06-25 | 2003-03-28 | Szekeres Gyoergy Dr | Hand instrument set for constructing tissue array |
| GB0229734D0 (en) | 2002-12-23 | 2003-01-29 | Qinetiq Ltd | Grading oestrogen and progesterone receptors expression |
| US7257268B2 (en) | 2003-02-28 | 2007-08-14 | Aperio Technologies, Inc. | Systems and methods for image pattern recognition |
| PL1601450T3 (en) | 2003-03-10 | 2014-03-31 | Expression Pathology Inc | Liquid tissue preparation from histopatologically processed biological samples, tissues and cells |
| US8068988B2 (en) | 2003-09-08 | 2011-11-29 | Ventana Medical Systems, Inc. | Method for automated processing of digital images of tissue micro-arrays (TMA) |
| EP3144675A1 (en) | 2005-04-28 | 2017-03-22 | Ventana Medical Systems, Inc. | Enzymes conjugated to antibodies via a peg heterobifuctional linker |
| AU2006239154A1 (en) | 2005-04-28 | 2006-11-02 | Ventana Medical Systems, Inc | Nanoparticle conjugates |
| EP1777523A1 (en) | 2005-10-19 | 2007-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method |
| CN104090095B (en) | 2005-11-23 | 2016-06-01 | 文塔纳医疗系统公司 | Molecular conjugate |
| US7629125B2 (en) | 2006-11-16 | 2009-12-08 | General Electric Company | Sequential analysis of biological samples |
| US7741045B2 (en) | 2006-11-16 | 2010-06-22 | General Electric Company | Sequential analysis of biological samples |
| US8023714B2 (en) | 2007-06-06 | 2011-09-20 | Aperio Technologies, Inc. | System and method for assessing image interpretability in anatomic pathology |
| CA2737116C (en) | 2008-09-16 | 2019-01-15 | Historx, Inc. | Reproducible quantification of biomarker expression |
| NZ593514A (en) | 2009-01-14 | 2013-03-28 | Us Health | p-mTOR and p-AKT as Ratio Based Biomarkers for the Prognosis and/or Diagnosis of Cancer |
| US20110111435A1 (en) | 2009-11-06 | 2011-05-12 | SlidePath Limited | Detecting Cell Surface Markers |
| SI2619576T1 (en) * | 2010-09-24 | 2021-03-31 | Niels Grabe | Means and methods for the prediction of treatment response of a cancer patient |
| EP3214185A1 (en) | 2010-12-01 | 2017-09-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for predicting the outcome of colon cancer by analysing mirna expression |
| EP3141617B1 (en) | 2011-01-11 | 2018-11-14 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting the outcome of a cancer in a patient by analysing gene expression |
| JP6116586B2 (en) | 2012-01-20 | 2017-04-19 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | A method for prognosis of survival of patients with solid cancer |
| EP2805165B1 (en) | 2012-01-20 | 2018-03-14 | INSERM - Institut National de la Santé et de la Recherche Médicale | Methods for predicting the survival time of a patient suffering from a solid cancer based on density of b cells |
| DE13731071T1 (en) | 2012-06-14 | 2016-08-18 | Assistance Publique Hôpitaux De Paris | Method for the quantification of immune cells in tumor tissue and its applications |
| DK2872646T3 (en) | 2012-07-12 | 2017-12-04 | Université Paris Descartes | PROCEDURES FOR PREDICTING SURVIVAL TIME AND TREATMENT RESPONSE OF A PATIENT, SUFFERING A FAST CANCER WITH A SIGNATURE OF AT LEAST 7 GENES |
| LT2880180T (en) | 2012-08-06 | 2019-01-25 | Institut National De La Santé Et De La Recherche Médicale (Inserm) | Methods and kits for screening patients with a cancer |
| US9851357B2 (en) | 2013-07-15 | 2017-12-26 | Inserm (Institute National De La Sante Et De La Recherche Medicale | Method for the prognosis of survival time of a patient suffering from a solid cancer |
| CN115198018A (en) | 2016-05-09 | 2022-10-18 | 法国国家卫生及研究医学协会 | Method for classifying patients with solid cancer |
| US20190167776A1 (en) * | 2016-08-05 | 2019-06-06 | Duke University | Camkk2 inhibitor compositions and methods of using the same |
| CN106501516B (en) * | 2016-12-16 | 2018-08-17 | 南方医科大学南方医院 | A kind of reagent and system for postoperative gastric cancer prognosis and chemosensitivity assessment |
-
2020
- 2020-06-03 SG SG11202112712RA patent/SG11202112712RA/en unknown
- 2020-06-03 CN CN202080040741.6A patent/CN114072676A/en active Pending
- 2020-06-03 US US17/616,519 patent/US20220236276A1/en active Pending
- 2020-06-03 BR BR112021024374A patent/BR112021024374A8/en not_active Application Discontinuation
- 2020-06-03 CA CA3142293A patent/CA3142293A1/en active Pending
- 2020-06-03 WO PCT/EP2020/065289 patent/WO2020245155A1/en unknown
- 2020-06-03 AU AU2020288603A patent/AU2020288603A1/en active Pending
- 2020-06-03 JP JP2021571865A patent/JP2022536075A/en active Pending
- 2020-06-03 EP EP20728790.5A patent/EP3977130A1/en active Pending
-
2021
- 2021-11-28 IL IL288491A patent/IL288491A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112021024374A8 (en) | 2022-12-06 |
| CN114072676A (en) | 2022-02-18 |
| BR112021024374A2 (en) | 2022-01-18 |
| EP3977130A1 (en) | 2022-04-06 |
| WO2020245155A1 (en) | 2020-12-10 |
| JP2022536075A (en) | 2022-08-12 |
| US20220236276A1 (en) | 2022-07-28 |
| IL288491A (en) | 2022-01-01 |
| CA3142293A1 (en) | 2020-12-10 |
| AU2020288603A1 (en) | 2021-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL290041A (en) | A scope | |
| GB201805954D0 (en) | A method | |
| GB201901025D0 (en) | A method for a holographic projector | |
| IL286681A (en) | Compounds and methods for modulating ube3a-ats | |
| GB2580862B (en) | Method for use with a radiotherapy device | |
| IL288491A (en) | Methods for modulating a treatment regimen | |
| EP4069087A4 (en) | Cover for a radiotherapy device | |
| EP3947869C0 (en) | Closure-securing means for a bottle | |
| GB2582817B (en) | A closure for securing two pieces together | |
| GB201813722D0 (en) | A method | |
| IL286127A (en) | A scope | |
| GB2577858B (en) | Method for use with a radiotherapy device | |
| GB201907110D0 (en) | Device for heart repair | |
| GB201813730D0 (en) | A method | |
| GB201809530D0 (en) | A method | |
| GB201808039D0 (en) | A method | |
| GB2586133B (en) | Method for use with a Radiotherapy Device | |
| GB2574434B (en) | Counterlung for a rebreathing apparatus | |
| GB2590648B (en) | Radiotherapy apparatus | |
| GB2589923B (en) | Strapping apparatus | |
| GB201900794D0 (en) | A method | |
| GB201918877D0 (en) | A closure | |
| GB201915492D0 (en) | A closure | |
| GB201912520D0 (en) | Compliance method | |
| GB2586472B (en) | A bung device |